12 Best Performing NASDAQ Stocks in 2022
The S&P 500 rose 0.6% to 3,844.82 on December 23, while the Nasdaq Composite gained 0.2% to close at 10,497.86. The Dow Jones Industrial Average also closed 176.44 points or 0.5% higher at 33,203.93.
Catalyst Pharmaceuticals Inc. (CPRX)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
12 Best Performing Biotech Stocks in 2022
Fitch Ratings has assigned a Neutral rating to the global pharmaceutical and biotech industry, which indicates the assumption of a collaborative operating backdrop in 2023, although inflationary pressures...
5 Biotech Stocks With The Biggest Upside
In this article, we discuss the 5 biotech stocks with the biggest upside.
12 Best Small-Cap Healthcare Stocks To Buy Now
Macroeconomic headwinds and recessionary concerns will not weaken healthcare deals next year after the market experienced resilient mergers and acquisitions in 2022.
10 Robinhood Stocks To Buy That Are Too Cheap To Ignore
In this article, we will be taking a look at 10 Robinhood stocks to buy that are too cheap to ignore.
10 Best Robinhood Stocks To Buy Right Now
Stock trading applications like Robinhood Markets, Inc. (NASDAQ:HOOD) are becoming more popular as tech-enabled disruption sweeps the world of finance.
10 Growth Stocks Under $20 in Billionaire Ken Fisher's Portfolio
In this article, we discuss the 10 growth stocks under $20 in billionaire Ken Fisher's portfolio.
5 New Stock Picks of Billionaire Ken Fisher
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is a biotech firm that develops therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases.
5 Best Stocks for Long Term Growth
Sundial Growers Inc. (NASDAQ: SNDL) is a firm that makes and sells cannabis products. Its dried flower cannabis products are available in a variety of formats, including pre-rolls, oils and capsules.
5 Cheap Pharmaceutical Stocks to Watch
In this article, we discuss the 5 cheap pharmaceutical stocks to watch.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
